Why is iRhythm Technologies, Inc. ?
- The company has declared positive results for the last 5 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 86 MM
- ROCE(HY) Highest at -9.63%
- RAW MATERIAL COST(Y) Fallen by -2.32% (YoY)
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
How much should you buy?
- Overall Portfolio exposure to iRhythm Technologies, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is iRhythm Technologies, Inc. for you?
High Risk, Medium Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at USD 86 MM
Highest at -9.63%
Fallen by -2.32% (YoY
Highest at USD 1,140.89 MM
Lowest at 73.17 %
Highest at 9.92 times
Highest at USD 224.17 MM
Highest at USD 25.23 MM
Highest at 11.26 %
Highest at USD 19.82 MM
Highest at USD 19.82 MM
Lowest at 11.52 times
Here's what is working for iRhythm Technologies, Inc.
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Operating Cash Flows (USD MM)
Net Sales (USD MM)
Operating Profit (USD MM)
Operating Profit to Sales
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Cash and Cash Equivalents
Debt-Equity Ratio
Debtors Turnover Ratio
Raw Material Cost as a percentage of Sales
Depreciation (USD MM)
Here's what is not working for iRhythm Technologies, Inc.
Inventory Turnover Ratio






